139 related articles for article (PubMed ID: 9851271)
1. Interleukin-10 inhibits the capacity of synovial macrophages to function as antigen-presenting cells.
Möttönen M; Isomäki P; Saario R; Toivanen P; Punnonen J; Lassila O
Br J Rheumatol; 1998 Nov; 37(11):1207-14. PubMed ID: 9851271
[TBL] [Abstract][Full Text] [Related]
2. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10.
MacDonald KP; Pettit AR; Quinn C; Thomas GJ; Thomas R
J Immunol; 1999 Nov; 163(10):5599-607. PubMed ID: 10553089
[TBL] [Abstract][Full Text] [Related]
3. Activation and differentiation of myelomonocytic cells in rheumatoid arthritis and healthy individuals--evidence for antagonistic in vitro regulation by interferon-gamma and tumor necrosis factor alpha, granulocyte monocyte colony stimulating factor and interleukin 1.
Seitz M; Zwicker M; Pichler W; Gerber N
J Rheumatol; 1992 Jul; 19(7):1038-44. PubMed ID: 1380987
[TBL] [Abstract][Full Text] [Related]
4. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
7. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells.
Thomas R; Davis LS; Lipsky PE
J Immunol; 1994 Mar; 152(5):2613-23. PubMed ID: 7510751
[TBL] [Abstract][Full Text] [Related]
9. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS
Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298
[TBL] [Abstract][Full Text] [Related]
11. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
[TBL] [Abstract][Full Text] [Related]
12. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
[TBL] [Abstract][Full Text] [Related]
15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
16. Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
Zijlmans HJ; Fleuren GJ; Baelde HJ; Eilers PH; Kenter GG; Gorter A
Cancer; 2007 Feb; 109(3):556-65. PubMed ID: 17177206
[TBL] [Abstract][Full Text] [Related]
17. Functional differentiation of dendritic cells in rheumatoid arthritis: role of CD86 in the synovium.
Thomas R; Quinn C
J Immunol; 1996 Apr; 156(8):3074-86. PubMed ID: 8609431
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells induced in the presence of GM-CSF and IL-5.
Yi H; Zhang L; Zhen Y; He X; Zhao Y
Cytokine; 2007 Jan; 37(1):35-43. PubMed ID: 17382554
[TBL] [Abstract][Full Text] [Related]
19. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
Eksioglu EA; Mahmood SS; Chang M; Reddy V
Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
